Citigroup
AEON icon

Citigroup’s AEON Biopharma AEON Stock Holding History

Citigroup’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$731 Buy
+742
New +$829 ﹤0.01% 5507
2025
Q3 		– Sell
-272
Closed -$207 – 6054
2025
Q2 		$207 Buy
+272
New +$156 ﹤0.01% 5478
2022
Q3 		– Sell
-347
Closed -$245K – 5781
2022
Q2 		$245K Hold
347
– – ﹤0.01% 3729
2022
Q1 		$245K Hold
347
– – ﹤0.01% 3959
2021
Q4 		$243K Buy
+347
New +$244K ﹤0.01% 4250

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup's AEON Position: Q1 2026 in Review

Citigroup opened a new position in AEON Biopharma (AEON) in Q1 2026: 742 shares worth $731. The stake represents ﹤0.01% of the portfolio and ranks #5507 among its holdings. This is a return to the name: Citigroup previously reported a position in AEON as recently as Q2 2025.

Citigroup first reported a position in AEON in Q4 2021 and has held it in 5 quarters since. The position peaked at $245K in Q2 2022. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

  • Citigroup held 742 shares of AEON Biopharma worth $731 as of Q1 2026.
  • AEON Biopharma was a new Citigroup position in Q1 2026.
  • AEON Biopharma made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5507 holding.
  • Citigroup first reported a position in AEON Biopharma in Q4 2021 and has held it in 5 quarters since.
  • Citigroup's AEON Biopharma position peaked at $245K in Q2 2022.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.